Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014-Reference-Cited by-同舟云学术

Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014

Published:2015-03-10 Issue:2 Volume:62 Page:627-634
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Torok Natalie J.¹,Dranoff Jonathan A.²,Schuppan Detlef³⁴,Friedman Scott L.⁵

Affiliation:

1. Department of Gastroenterology and Hepatology; UC Davis Medical Center, Sacramento; CA and VA Northern California Healthcare System Mather CA

2. Division of Gastroenterology and Hepatology; University of Arkansas for Medical Sciences; Little Rock, AR, and Research Service, Central Arkansas VA Healthcare System Little Rock AR

3. Institute of Translational Immunology and Research Center for Immunotherapy; University Medical Center; Mainz Germany

4. Division of Gastroenterology; Beth Israel Deaconess Medical Center, Harvard Medical School; Boston MA

5. Division of Liver Diseases; Icahn School of Medicine at Mount Sinai; New York NY

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27720/fullpdf

Reference75 articles.

1. The changing burden of hepatitis C virus infection in the United States: model-based predictions;Kabiri;Ann Intern Med,2014

2. Liver fibrosis in 2012: convergent pathways that cause hepatic fibrosis in NASH;Friedman;Nat Rev Gastroenterol Hepatol,2013

3. Evolving therapies for liver fibrosis;Schuppan;J Clin Invest,2013

4. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection;Regev;Am J Gastroenterol,2002

5. Sampling variability of liver biopsy in nonalcoholic fatty liver disease;Ratziu;Gastroenterology,2005

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet index ratios in HIV: Emerging biomarkers for immune health and disease management;Medicine;2024-03-22

2. Introduction;Biochemistry of Collagens, Laminins and Elastin;2024

3. Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers;Biomaterials;2023-11

4. Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges;International Journal of Molecular Sciences;2023-02-26

5. Current strategies for targeted therapy of liver fibrosis;Bulletin of Siberian Medicine;2022-10-15